Abstract

Acule coronary syndrome and congestive heart failure are still among challenging problems in the field of cardiovascular medicine despite many advances in the field. Stem cell therapy has come as a new hope and a promise for the hopeless.

Highlights

  • Acule coronary syndrome and congestive heart failure are still among challenging problems in the field of cardiovascular medicine despite many advances in the field

  • Results of various reports including BOOST trial TECAM pilot study TOP CARE- AMI trial and many more have investigated the role of stem cell as a therapy for cardiac regeneration in an effort to replace cardiomyocytes lost after ischemia

  • The HSC produce all types of formed elements of blood and are isolated from either the bone marrow or blood

Read more

Summary

Introduction

Acule coronary syndrome and congestive heart failure are still among challenging problems in the field of cardiovascular medicine despite many advances in the field. The adult and embryonic stem cell may be able to replace damaged heart muscle and establish and grow new blood vessel to supply them, Embryonic stem cells as their name suggests are derived from embryos. Human embryomie and adult stem cells each have advantages and disadvantages Regarding potential use of cell based regenerate therapies.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.